Findlay DM - Search Results

1

Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.

Evdokiou A, Atkins GJ, Bouralexis S, Hay S, Raggatt LJ, Cowled PA, Graves SE, Clayer M, Findlay DM. Evdokiou A, et al. Among authors: findlay dm. Int J Oncol. 2001 Sep;19(3):625-32. doi: 10.3892/ijo.19.3.625. Int J Oncol. 2001. PMID: 11494046

2

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.

Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M, Findlay DM. Evdokiou A, et al. Among authors: findlay dm. Int J Cancer. 2002 Jun 1;99(4):491-504. doi: 10.1002/ijc.10376. Int J Cancer. 2002. PMID: 11992538

3

Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.

Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM. Atkins GJ, et al. Among authors: findlay dm. J Bone Miner Res. 2000 Apr;15(4):640-9. doi: 10.1359/jbmr.2000.15.4.640. J Bone Miner Res. 2000. PMID: 10780856 Free article.

4

Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.

Atkins GJ, Bouralexis S, Haynes DR, Graves SE, Geary SM, Evdokiou A, Zannettino AC, Hay S, Findlay DM. Atkins GJ, et al. Among authors: findlay dm. Bone. 2001 Apr;28(4):370-7. doi: 10.1016/s8756-3282(01)00404-5. Bone. 2001. PMID: 11336917

5

Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin.

Bouralexis S, Clayer M, Atkins GJ, Labrinidis A, Hay S, Graves S, Findlay DM, Evdokiou A. Bouralexis S, et al. Among authors: findlay dm. Int J Oncol. 2004 May;24(5):1263-70. doi: 10.3892/ijo.24.5.1263. Int J Oncol. 2004. PMID: 15067350

6

RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone.

Atkins GJ, Kostakis P, Vincent C, Farrugia AN, Houchins JP, Findlay DM, Evdokiou A, Zannettino AC. Atkins GJ, et al. Among authors: findlay dm. J Bone Miner Res. 2006 Sep;21(9):1339-49. doi: 10.1359/jbmr.060604. J Bone Miner Res. 2006. PMID: 16939392 Free article.

7

Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model.

Labrinidis A, Hay S, Liapis V, Findlay DM, Evdokiou A. Labrinidis A, et al. Among authors: findlay dm. Int J Cancer. 2010 Jul 15;127(2):345-54. doi: 10.1002/ijc.25051. Int J Cancer. 2010. PMID: 19924813

8

Osteoblast-chondrocyte interactions in osteoarthritis.

Findlay DM, Atkins GJ. Findlay DM, et al. Curr Osteoporos Rep. 2014 Mar;12(1):127-34. doi: 10.1007/s11914-014-0192-5. Curr Osteoporos Rep. 2014. PMID: 24458429 Free PMC article. Review.

9

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer.

Zinonos I, Luo KW, Labrinidis A, Liapis V, Hay S, Panagopoulos V, Denichilo M, Ko CH, Yue GG, Lau CB, Ingman W, Ponomarev V, Atkins GJ, Findlay DM, Zannettino AC, Evdokiou A. Zinonos I, et al. Among authors: findlay dm. Int J Oncol. 2014 Aug;45(2):532-40. doi: 10.3892/ijo.2014.2468. Epub 2014 May 27. Int J Oncol. 2014. PMID: 24865346 Free PMC article.

10

Calcitonin receptor-mediated growth suppression of HEK-293 cells is accompanied by induction of p21WAF1/CIP1 and G2/M arrest.

Evdokiou A, Raggatt LJ, Atkins GJ, Findlay DM. Evdokiou A, et al. Among authors: findlay dm. Mol Endocrinol. 1999 Oct;13(10):1738-50. doi: 10.1210/mend.13.10.0359. Mol Endocrinol. 1999. PMID: 10517675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters